Literature DB >> 10767390

Distribution of serum apolipoproteins A-I and B and lipoprotein(a) in European elderly. The SENECA study.

J H Contois1, A H Wu, Z Li, A H Feroze, F Grunenberger, J Haller, L deGroot, C J Lammi-Keefe.   

Abstract

The purpose of this study is to describe sex and geographic differences in apolipoproteins (apo) A-I and B and lipoprotein(a) [Lp(a)] concentrations in elderly Europeans. Subjects were 2164 elderly participants of the SENECA study from different regions of Europe. Sera for apo A-I, apo B, and Lp(a) measurement were available for 1703 individuals. In men, mean values ranged from 1.38 to 1.79 g/l for apo A-I, 1.03-1.36 g/l for apo B, and 0.26-0.67 g/l for Lp(a). In women, mean values ranged from 1.54 to 1.98, 1.20-1.51, and 0.26-0.68 g/l for apo A-I, apo B, and Lp(a), respectively. A comparison of northern (Norway, Denmark, Netherlands), middle (France, Switzerland), and southern (Portugal, Spain, Italy, Greece) communities showed a less atherogenic profile in the south, including lower LDL cholesterol, apo B, TC/HDL cholesterol ratio, and apoB/apo A-I ratio. Men, but not women, also had significantly higher HDL cholesterol and apo A-I concentrations in the South. Paradoxically, Lp(a) concentrations were generally high among all elderly and were significantly higher in the southern communities. These data show that the elderly in Europe are very heterogeneous with respect to plasma lipoproteins, including apo A-I, apo B, and Lp(a).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767390     DOI: 10.1016/s0009-8981(00)00187-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.

Authors:  Stefan Coassin; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

2.  Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.

Authors:  Christoph Waldeyer; Nataliya Makarova; Tanja Zeller; Renate B Schnabel; Fabian J Brunner; Torben Jørgensen; Allan Linneberg; Teemu Niiranen; Veikko Salomaa; Pekka Jousilahti; John Yarnell; Marco M Ferrario; Giovanni Veronesi; Paolo Brambilla; Stefano G Signorini; Licia Iacoviello; Simona Costanzo; Simona Giampaoli; Luigi Palmieri; Christa Meisinger; Barbara Thorand; Frank Kee; Wolfgang Koenig; Francisco Ojeda; Jukka Kontto; Ulf Landmesser; Kari Kuulasmaa; Stefan Blankenberg
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

3.  Lower serum triglyceride levels linked to more severe motor performance in Parkinson's disease.

Authors:  Meimei Zhang; Huimin Chen; Genliang Liu; Xuemei Wang; Zhan Wang; Tao Feng; Yumei Zhang
Journal:  Neurol Sci       Date:  2022-05-24       Impact factor: 3.830

Review 4.  Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases.

Authors:  Catherine Coremans; Cédric Delporte; Frédéric Cotton; Phillipe Van De Borne; Karim Zouaoui Boudjeltia; Pierre Van Antwerpen
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.